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Abstract 
The effects of administration of yohimbine, an aphrodisiac on some functional parameters of rat 
liver and kidney were investigated. White male albino rats weighing between 200-250g were 
grouped into two such that one group was orally administered with 14mg/kg body weight on 
daily basis for 15days while the control received an appropriate volume of sterile distilled water 
on daily basis for the same period. Bilirubin concentration in the test showed a significant 
decrease (P<0.01) when compared with the control, with an interruption of a significant increase 
only on day 5 of administration (P<0.01). Sodium ion concentration showed significant increase 
only on the first and the last days when compared with the control (P<0.01). The serum albumin 
content and K+ displayed significant increase throughout the experimental period (P<0.01) while 
serum content of urea and creatinine decreased significantly throughout the period of 
administration (P<0.01). The results suggest that yohimbine administration has adverse affect on 
the functional capacities of the liver and the kidney. 
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INTRODUCTION      
      
There is no known condition more devastating to a 
man’s ego than impotence. It annihilates his very 
essence of masculinity1. Impotence or erectile 
dysfunction is the persistent inability to achieve or 
maintain an erection of the male copulatory organ 
sufficient for the purpose of a satisfactory sexual 
performance2. It is not a disease in itself, but a 
symptom of an underlying disease in 80% of all 
occasions3.The disorder which is age associated is 
with an estimated prevalence rate of 5% among 
men 40 years old and 15% among those 70 years 
old4. 
     The complex nature of human sexual response 
and penile physiology makes erectile dysfunction 
to have many different causes. Common causes 
include psychological, endocrine abnormalities, 
systemic illness, radiation treatment for prostate 
cancer, side effect of drugs, life style and aging. 
The mainstay of erectile dysfunction treatment 
include psychotherapy, diet, testosterone 
supplementation, intraurethral pellets (MUSE), 
vacuum device, penile injections, penile implants, 
surgery, phytotherapy and oral therapy such as 
viagra, yohimbine3,5,6,7,8. 
     Yohimbine is the principal indole alkaloid 
derived from the bark of the Yohimbe Tree 
(Pausinystalia yohimbe = Corynanthe yohibi) 
(Family, Rubiaceae). It is also found in Rauwolfia 
serpentine and the dried bark of Aspidosperma 
quebracho9. The evergreen forest tree is native to 
southwestern Nigeria, Cameroon, Gabon and the 
Congo. Yohimbe bark contains up to 6% indole 
alkaloids, 10-15% of which are yohimbine; also -
yohimbine, allo-yohimbine(dihydroyohimbine), 
yohimbinine, -yohimbane, yohimbenine and 
corynatheine10. The main alkaloid is yohimbine. It 
is a monoamine oxidase inhibitor11. It is a true 
aphrodisiac since it increases arousal in sexually 
inexperienced male rats, facilitates copulation in 
sexually naïve males and increases sexual activity 
in males that were previously sexually inactive5. It 
has been used as a possible treatment for organic, 
psychogenic and substance induced erectile 
impotence and other male sexual dysfunctions. Its 
effect on male sexual performance is possibly 
related to its peripheral autonomic nervous system 
effects12. It increases blood flow to erectile tissues 
and may increase testosterone levels13. Currently, 
it is assumed that Yohimbine exerts its erectogenic 
effect through a central action14. Side effects 
include elevated blood pressure and heart rate, 
irritability, headache and dizziness14. 
     Studies have shown the effect of pH and 
binding of ten physiologically active compounds 
including yohimbine on the molecular structure of 
human serum albumin15, and the effect of 
clonidine on sodium and potassium excretions 
after previous administration of prozasin and 
yohimbine into the ventromedial nucleus of 
hypothalamus of conscious rats16, but information 
on its effect of administration on selected 
functional indices of rat kidney and liver appears 
to be scanty. This work is therefore set out to 
provide information on the effect, if any, of 
repeated administration of yohimbine at the 
required therapeutic dose of 14mg/kg body weight 
on selected functional indices of rat liver and 
kidney. This was evaluated by monitoring some 
function tests for the rat liver and kidney. 
 
MATERIALS AND METHODS 
 
Animals and Assay Kits 
     A total of twenty-five male, white albino 
rats(Rattus novergicus) weighing between 200-
250g were obtained from the small Animal 
Breeding Unit of the Department of Biochemistry, 
University of Ilorin, Ilorin, Nigeria. Yohimbine 
was supplied by MLO Product, Fairfield, U.S.A. 
The albumin and bilirubin assay kits were 
obtained from Randox Laboratories, Ltd., United 
Kingdom while the urea and creatinine assay kits 
were supplied by Quinica Clinica Applicada, S. 
A., Spain. Other reagents used were of analytical 
grade and were prepared in all glass-distilled 
water. 
 
Animal Groupings and Drug Administration. 
     The rats which had been maintained on normal 
rat chow and water ad libitum were allowed to 
acclimatize for seven days after which they were 
randomly grouped into two: (i) Group A- which 
consisted of 5 rats received orally 1ml sterile 
distilled water on daily basis. This served as the 
control. (ii) Group B- which consisted of 20 rats 
received orally appropriate volume        
corresponding to the therapeutic dose of 14mg/kg 
body weight of yohimbine preparation on daily 
basis. This served as the test group. Five rats each 
in group A were sacrificed 24hours after 1, 5, 10 
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and 15 daily doses of yohimbine while the 
remaining five rats in the control group were 
sacrificed 24hours after the 15 daily doses of 
sterile distilled water17. 
 
Serum Preparation 
     The rats were anaesthetized using cotton wool 
soaked in chloroform vapour. When they became 
unconscious, they were quickly brought out of the 
jar. The neck area was cleared of fur and skin to 
expose the jugular veins. These veins were then 
cut sharply with sterile scapel blade and the rats 
were held head downwards and allowed to bleed 
into clean dry corked test tubes, allowed to clot 
and left for 10mins at room temperature for serum 
formation18. The serum was collected using 
Pasteur pipette after centrifugation at 3000rpm for 
5minutes19, kept frozen and used for the various 
liver and kidney function analyses within 12hours 
of collection. 
 
Determination of Biochemical Parameters 
     Serum albumin concentration was determined 
based on its quantitative binding to the indicator 3, 
3’, 5, 5’-tetrabromo-m-cresol sulphonaphthalein 
(bromocresol green, BCG) which absorb 
maximally at 578nm20 while the method of Evelyn 
and Malloy21 was used to determine the serum 
bilirubin content of the samples. Sodium and 
potassium ions concentrations in the serum were 
measured using the flame photometer as described 
by Bassir22. Concentration of creatinine was 
determined using the method of Tietz et al23 while 
the method of Kaplan24 was employed to 
determine the serum urea concentration. 
 
Statistical analysis 
     Values obtained were subjected to test of 




     Tables 1 and 2 depict the effect produced on 
selected functional indices of rat liver and kidney 
respectively following the repeated administration 
of yohimbine. Yohimbine administration resulted 
in an initial significant decrease in serum content 
of bilirubin (P<0.01) and by the fifth day, the 
concentration has increased significantly when 
compared with the control (P<0.01) (Table 1). The 
bilirubin concentration compared favourably with 
the control by the tenth day of administration, a 
trend which was not sustained beyond that day as 
there was significant reduction in bilirubin 
concentration of about half the control value 
(P<0.01) (Table I). The serum albumin 
concentration displayed a general pattern of 
significant increase right from the start of the drug 
administration and was sustained throughout the 
experimental period (P<0.01) (Table I). 
     There was an initial significant increase in Na+ 
concentration (P<0.01) which was not sustained 
beyond the first day as the values thereafter 
compared favourably with the control (P>0.01). 
This was thereafter followed by another significant 
increase in Na+ concentration by the end of drug 
administration (P<0.01) (Table II). In contrast, K+ 
concentration increased significantly right from 
the start of drug administration and this trend was 
sustained throughout the experimental period 
(P<0.01). Compared with the control, yohimbine 
administration produced significant reduction in 
the serum concentration of urea and creatinine 
throughout the experimental period (P<0.01), with 
the reduction being about half the control value in 
the urea and creatinine concentration by the end of 




     The biochemical indices evaluated in this study 
are useful parameters to indicate impairment in 
functional capacities of the organs. However, there 
is no single test for measuring liver function, 
because all the functions of the liver are not 
equally or simultaneously affected in hepatobillary 
disorder. Consequently, a battery of tests assessing 
a variety of hepatic functions has to be 
simultaneously performed. The concentration of 
the proteins, bilirubin and albumin in the serum 
can indicate the state of the liver and can be used 
to ascertain different types of liver damage.  
     The non-definite pattern of serum bilirubin 
concentration observed in the first five days of 
administration (Table 1) may be attributed to 
various attempts by the tissue to adapt to the effect 
of the drug17,26, which was eventually achieved by 
the tenth day of administration (Table 1). Further 
attempt at complete adaptation to the adverse 
effect of yohimbine failed, leading to reduction in 
concentration of half its control value by the end 
of administration (Table 1). Consequently, the  
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Table 1: Effect of daily administration of yohimbine (14mg/kg body weight) 
on some rat liver function parameters 
            ____________________________________________________________ 
             Days after                                 Albumin                           Total Bilirubin 
             Administration                            (g/L)                                 (umol/L) 
            ____________________________________________________________ 
             Control                                 19.00±0.71                                 7.20±0.07 
                   1                                     24.40±1.14**                             5.40±0.86** 
                   5                                     26.00±1.00**                            10.30±1.50** 
                  10                                    23.00±1.00**                              6.56±2.75* 
                  15                                    25.00±0.71**                              3.90±0.07** 
           _____________________________________________________________ 
  Statistical significance were tested using Student’s t-test; compared with control  




Table 2: Effect of daily administration of yohimbine (14mg/kg body weight) on 
some rat kidney function parameters 
           _________________________________________________________________ 
             Days after              Na+                  K+                    Creatinine               Urea 
             Administration   (mmol/L)        (mmol/L)               (mmol/L)            (mmol/L) 
            _________________________________________________________________ 
             Control           122.00±0.71        5.30±0.07         330.00±0.71          18.30±0.07                    
                   1               148.00±2.00**    5.84±0.38**     232.00±12.21**    13.16±0.71**                    
                   5               119.00±5.00*    11.38±2.57**     226.00±17.29**    12.62±0.95**                    
                  10              127.00±7.00*      8.70±0.60**     200.00±20.00**    11.24±0.95**                     
                  15              128.00±0.71**    6.56±0.09**     187.00±0.71**      10.40±0.07**                      
            __________________________________________________________________ 
Statistical significance were tested using Student’s t-test; compared with control values, *p>0.01; 
**p<0.01, ±SD, n=5 
 
 
hypobilirubinemia is an indication of 
impairment of the tissue’s functional capacity as 
extensive liver damage may lead to decrease 
serum levels of bilirubin27. 
     Liver is the exclusive site of synthesis of 
albumin. The observed hyperalbuminemia 
(Table 1), although, a rare occurrence could be 
attributed to severe dehydration28. It may also be 
adduced to increased rate of hepatic synthesis of 
albumin without a proportionate increase in the 
rate of its catabolism. Consequently, the amino 
acid pool will no longer be maintained within 
normal limits. The hyperalbuminemia may 
adversely affect the transportation of a wide 
variety of ligands to the organs and tissues for 
their utilization or excretion. It may also lead to 
hyper-osmotic pressure28. The observed 
hyperalbimnemia throughout the drug 
administration may be an indication that the 
increase in albumin synthesis is dependent only 
upon initial drug administration and not the 
duration. 
     The functional capacity of the kidney can be 
measured by the dye excretion tests, clearance 
test, concentration and dilution tests and method 
for examination of blood concentrations of 
excretory and electrolyte constituents. 
Furthermore, renal function tests are required 
either to demonstrate the presence or absence of 
active lesion in the kidney, or to assess the 
normal functioning capacity of different parts of 
the functioning unit, nephron29. Inorganic 
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electrolytes occur in large quantities in both 
extracellular and intracellular fluids. Due to their 
ability to dissociate readily into their constituent 
ions or radicals, they comprise the single most 
important factor in the transfer and movement of 
water and electrolytes between three divisions of 
the extracellular and intracellular 
compartment30. The initial profile of serum Na+ 
concentration (Table 2) may be adduced to 
attempt at counteracting the effect of the drug26. 
By the end of the experimental period, the 
functional capacity was compromised by the 
nephron with significant increase in Na+ 
concentration (Table 2), probably resulting from 
excessive loss of Na+ pool body fluids. It may 
also be due to either increase production of 
aldosterone and other mineralcorticoids which 
will in turn increase the tubular reabsorption of 
Na+ or decreased production of either 
antidiuretic hormone or decreased tubular 
sensitivity to the hormone23. Hypernatraemia 
could in a way serve as an indicator of liver 
disease31. Potassium ions play an important role 
in the way in which nerve impulses are 
propagated along the nerve cells and transmitted 
to receptor cells. The sodium pump maintains 
the intracellular K+ concentration of 140mM as 
against the extracellular K+ concentration of 
5mM32. The hyperkalaemia observed in the first 
ten days of administration (Table 2) suggests a 
possible adverse effect on the pump that 
maintains the constancy of its extracellular 
concentration. Hyperkalaemia is a more 
dangerous condition because of its effect on the 
heart, but it rarely occurs unless renal function is 
depressed. It may result in the paralysis of the 
atria and ventricular arrhythmias may develop. 
The muscle fibres may eventually become 
unexcitable, and the heart stops in diastole33. 
However, the no significant difference from the 
control value by the end of drug administration 
may be that the system has successfully 
combated the adverse effect of yohimbine, an 
indication that it may be of low toxicity to the 
monovalent ion.  
     Urea is the major nitrogen-containing 
metabolic product of protein catabolism. The 
significant reduction in serum urea concentration 
throughout the experimental period may be 
attributed to impairment of the urea cycle 
leading to reduced production of the metabolic 
product. Since biosynthesis of urea could be 
divided into four stages of transamination, 
oxidative deamination of glutamate, ammonia 
transport and reactions of the urea cycle34 and 
since it has been evaluated by this same set of 
authors that yohimbine administration resulted 
in reduction in serum transaminases (Glutamate 
oxaloacetate transaminase and Glutamate 
pyruvate transaminase), it seems logical that the 
aphrodisiac may be affecting the transamination 
stage of the urea cycle. This is an indication of 
abnormality in the physiological excretion of 
urea caused by a non-renal factor35. 
Consequently, since urea synthesis converts 
toxic ammonia to non toxic urea, defects in urea 
synthesis as observed in this study (Table 2) 
may result in ammonia intoxication. 
     The significant reduction in creatinine, 
another product of protein metabolism from the 
start of drug administration to half the control 
value by the end of drug administration may be 
an indication of compromise of the renal 
function. Yohimbine might have adversely 
interfered with the metabolism of creatinine 
leading to its observed reduction, an indication 
of partial loss of its functional capacity of 
tubular excretion30.  
     The various alterations in the functional 
indices of the tissues and their values which do 
not compare favourably with their control values 
are clear manifestation of adverse effects of the 
functional parameters evaluated following the 
daily administration of the aphrodisiac. This 
study suggests that repeated administration of 
yohimbine has some deleterious effect on the 
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